CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
- Monday, May 16, 2022, 7:18
- PR Newswire
- Add a comment
Recent approvals of potentially pivotal Berubicin Study into Switzerland, France, and Spain expected to significantly drive patient enrollment Opportunities for Berubicin to be used in additional oncology indications with significant unmet needs HOUSTON, May 16, 2022 /PRNewswire/ — CNS…
About the Author
admin has written 21729 stories on this site.